Schedule 13D ownership disclosure

Tenaya Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 87990A106

Event date: 2025-12-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • The Column Group III, LPReported CIK 0001668159

    Shares: 4,414,720 · Class: 2.1%

  • The Column Group III-A, LPReported CIK 0001668085

    Shares: 4,985,570 · Class: 2.3%

  • The Column Group III GP, LPReported CIK 0001790965

    Shares: 9,400,290 · Class: 4.4%

  • The Column Group Opportunity III, LPReported CIK 0001931825

    Shares: 49,313,559 · Class: 23.1%

  • The Column Group Opportunity III GP, LPReported CIK 0001932874

    Shares: 49,313,559 · Class: 23.1%

  • TCG Opportunity III GP, LLCReported CIK 0001932445

    Shares: 49,313,559 · Class: 23.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-322770
Form type
SCHEDULE 13D/A
Filer
COLUMN GROUP III, LP
CIK
CIK 1668159
Filed
Dec 17, 2025
Reporting period
Dec 15, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub